Track topics on Twitter Track topics that are important to you
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 2, 2017 to file lead plaintiff applications in a securities class action lawsuit against The Advisory Board Company (NasdaqGS: ABCO), if they purchased the Company’s shares between January 21, 2015 and February 23, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Advisory Board investors should visit us at https://www.claimsfiler.com/cases/view-the-advisory-board-company-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Advisory Board and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company experienced significant problems with integration resulting from the acquisition of Royall; (ii) because of the integration problems, there were no grounds for increasing the revenue guidance for Royall during the relevant period; and (iii) as a result of the foregoing, the Advisory Board’s financial statements were materially false and misleading at all relevant times.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
Jerry Gallo, 844-367-9658
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...